Smriti Suri

About

PhD scholar at PGIMER, Chandigarh, investigating the biomarker potential of Lipocalin-2 (LCN2), Matrix Metalloproteinase-9 (MMP9) and the LCN2/MMP9 complex in Oral Squamous Cell Carcinoma (OSCC), with a focus on the molecular basis of radioresistance. Research spans molecular cloning, in-vitro gene knockdown, generation of radioresistant cell-line models, and clinical sample–based protein and gene-expression analysis. Various peer-reviewed publications and international travel awards from EACR, ANRF (AACR 2026), ICMR, and APFCB.

Employment

Employment history is unavailable.

Education

• Post Graduate Institute of Medical Education and Research Doctor of Philosophy
  2021 - Present
• University of Delhi Miranda House B.Sc.
  2014 - 2017

Projects & Funding

Projects & funding information is unavailable.

Publications (9)

• Exploring the biomarker potential of LCN2 and MMP9 proteins in Head and Neck Squamous Cell Carcinoma
  Scientific Reports 2026 DOI: 10.1038/s41598-026-76740-1
  +Save
• Recent advances in minimally invasive biomarkers of OSCC: from generalized to personalized approach
  Smriti Suri, Geeta S. Boora, Rajandeep Kaur

  +3 more

  • Anshika Chauhan
  • Sushmita Ghoshal
  • Arnab Pal
  Frontiers in Oral Health 2024 DOI: 10.3389/froh.2024.1426507
  +Save
• Role of interleukin-2 and interleukin-18 in newly diagnosed type 2 diabetes mellitus
  Smriti Suri, Prasenjit Mitra, Abhilasha Abhilasha +4 more
  Journal of Basic and Clinical Physiology and Pharmacology 2022 DOI: 10.1515/jbcpp-2020-0272
  +Save
• Downregulation of miR-24-3p and miR-198 in Newly Diagnosed type 2 Diabetes Mellitus
  Abhilasha Abhilasha, Prasenjit Mitra, Smriti Suri +4 more
  2021 DOI: 10.21203/rs.3.rs-1038581/v1
  +Save
• Downregulation of interleukin-10 receptor (IL-10R) along with low serum IL-10 levels in newly diagnosed type 2 diabetes mellitus patients
  Abhilasha, Prasenjit Mitra, Smriti Suri +4 more
  Gene Reports 2021 DOI: 10.1016/j.genrep.2021.101251
  +Save
• Altered expression of specific antioxidant (SOD1 and SOD2) and DNA repair (XRCC1 and OGG1) genes in patients with newly diagnosed type-2 diabetes mellitus.
  Smriti Suri, Prasenjit Mitra, Abhilasha ABHILASHA +4 more
  Minerva endocrinology 2021 DOI: 10.23736/s2724-6507.21.03417-5
  +Save
• Increased serum IL-18 levels and IL-18R expression in newly diagnosed type 2 diabetes mellitus
  Abhilasha Bankul, Prasenjit Mitra, Smriti Suri +4 more
  Minerva Endocrinologica 2020 DOI: 10.23736/S0391-1977.20.03271-X
  +Save
• Association of Comorbidities with Coronavirus Disease 2019: A Review
  Prasenjit Mitra, Smriti Suri, Taru Goyal +6 more
  Annals of the National Academy of Medical Sciences (India) 2020 DOI: 10.1055/s-0040-1714159
  +Save
• Inflammation, Immunity and Immunogenetics in COVID-19: A Narrative Review
  Malavika Lingeswaran, Taru Goyal, Raghumoy Ghosh +4 more
  Indian Journal of Clinical Biochemistry 2020 DOI: 10.1007/s12291-020-00897-3
  +Save